Related Experiment Video
Updated: Dec 17, 2025

Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Development of an implementation and evaluation strategy for the Australian 'Zero Childhood Cancer' (Zero) Program: a
Frances Rapport1, James Smith2, Tracey A O'Brien3,4
1Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, North Ryde, New South Wales, Australia frances.rapport@mq.edu.au.
This study evaluates the Zero Childhood Cancer Personalised Medicine Program, assessing its structure, process, and implementation effects for childhood cancer. Findings will guide future personalized medicine program development and sustainability.
Area of Science:
- Implementation Science
- Pediatric Oncology
- Personalized Medicine
Background:
- Effective research program implementation relies on actionable plans considering both scientific and execution aspects.
- The Zero Childhood Cancer Personalised Medicine Program (Zero Program) is a comprehensive initiative for high-risk or relapsed childhood cancers in Australia.
Purpose of the Study:
- To assess the structure, process, and implementational effects of the Zero Program.
- To evaluate the program's delivery mechanisms and collaborative links among stakeholders.
- To determine the sustainability and overall impact of the personalized medicine program.
Main Methods:
- A mixed-methods design incorporating rapid ethnography, implementation proformas, and social network analysis.
- Formative evaluations using feedback loops and professional input to identify areas for program tailoring.
- Summative evaluation involving data triangulation and an expert panel to assess integration of implementation strategies.
Main Results:
- The study is currently pre-results, with ongoing data collection and analysis.
- Evaluation will determine the effectiveness of collaborative links and group working on program outcomes.
- The integration of implementation strategies into the program structure will be assessed.
Conclusions:
- The comprehensive evaluation will provide insights into the Zero Program's success and sustainability.
- Findings will inform the refinement and future implementation of personalized medicine programs in pediatric oncology.
- Knowledge translation will be achieved through publications, reports, and presentations to diverse stakeholders.
More Related Videos
06:16Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting
Published on: June 6, 2020
11:13Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
Published on: November 10, 2021
Related Concept Videos
Cancer Prevention
Some...
Cancer Survival Analysis
Clinical Trials: Overview
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Treatment Resistant Cancers